Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

Diabetes

Volumn 47, Issue 1, 1998, Pages 93-97

  Gedulin, Bronislava R ^a   Young, Andrew A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; HUMAN INSULIN; PRAMLINTIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; INHIBITION KINETICS; INSULIN INFUSION; MALE; METABOLIC REGULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031963920     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.93     Document Type: Article

References (27)

1. Brener W, Hendrix TR, McHugh PR: Regulation of the gastric emptying of glucose. Gastroenterology 85:76-82, 1983
2. Young AA, Bogardus C, Stone K, Mott DM: Insulin response of components of whole-body and muscle carbohydrate metabolism in humans. Am J Physiol 254:E231-E236, 1988
3. Rink TJ, Beaumont K, Koda J, Young A: Structure and biology of amylin. Trends Pharmacol Sci 14:113-118, 1993
4. Young AA, Gedulin B, Vine W, Percy A, Rink TJ: Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38:642-648, 1995
5. Gedulin B, Green D, Jodka L, Young A: Endogenous amylin and gastric emptying in rats: comparison with GLP-1 and CCK-8 (Abstract). Diabetologia 38:A244, 1995
6. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA: Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 74:985-991, 1984
7. Nakanome C, Akai H, Kongo M, Imai N, Toyota T, Goto Y, Okuguchi F, Komatsu K: Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus. Tohoku J Exp Med 139:205-215, 1983
8. Nowak TV, Johnson CP, Kalbfleisch JH, Roza AM, Wood CM, Weisbruch JP, Soergel KH: Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 37:23-29, 1995
9. Nowak TV, Roza AM, Weisbruch JP, Brosnan MR: Accelerated gastric emptying in diabetic rodents: effect of insulin treatment and pancreas transplantation. J Lab Clin Med 123:110-116, 1994
10. Young AA, Gedulin BR, Rink TJ: Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 45:1-3, 1996
11. Gedulin BR, Jodka CM, Green DE, Rink TJ, Young AA: Reversal of amylin-inhibition of gastric emptying by insulin-induced hypoglycemia (Abstract). J Invest Med 44:160A, 1996
12. Scarpignato C, Capovilla T, Bertaccini G: Action of caerulein on gastric emptying of the conscious rat Arch Int Pharmacodyn Ther 246:286-294, 1980
13. Gedulin B, Jodka C, Green D, Rink T, Young A: Effect of the amylin receptor antagonist, AC 187, on gastric emptying of glucose in corpulent LA/N rats. In Proceedings of the American Diabetes Association 29th Research Symposium and the International Congress on Obesity, Boston, MA, August 1994, p. 40
14. Gedulin BR, Rink TJ, Young AA: Dose-response for glucagononstatic effect of amylin in rats. Metabolism 46:67-70, 1997
15. Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Gaeta LSL, Percy A, Moore CX, Koda JE, Rink TJ, Beaumont K: Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Development Research 37:231-248, 1996
16. Schvarcz E, Palmer M, Aman J, Lindkvist B, Beckman KW: Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus. Diabet Med 10:660-663, 1993
17. Schvarcz E, Palmer M, Aman J, Berne C: Atropine inhibits the increase in gastric emptying during hypoglycemia in humans. Diabetes Care 18:1463-1467, 1995
18. Gedulin B, Jodka C, Young A: Insulin-induced hypoglycaemia reverses pramlintide-inhibition of gastric emptying in rats. Diabet Med 14:S44 (P103), 1997
19. Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, Taoersall RB: Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40:82-88, 1997
20. Thompson R, Pearson L, Schoenfeld S, Kolterman O: Pramlintide, an analog of human amylin improves glycemic control in patients with type 2 diabetes requiring insulin (Abstract). Diabetes 40:30A, 1997
21. Thompson R, Kolterman OG, Peterson J, Pearson L: Pramlintide reduced 24-hour glucose concentrations and serum fructosamine in patients with type 1 diabetes mellitus (Abstract). Diabet Med 14 (Suppl. 2):A4, 1997
22. Thompson RG, Peterson J, Gottlieb A, Mullane J: Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial. Diabetes 46:632-636, 1997
23. The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial: the DCCT Research Group. Am J Med 90:450-459, 1991
24. Bueno L Assessment of CNS control of gastrointestinal motility. In Handbook of Methods in Gastrointestinal Pharmacology, Gaginella TS, Ed. Boca Raton, FL, CRC Press, 1996, p. 297-330
25. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K: In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62:553-567, 1994
26. Adachi A, Kobashi M, Funahashi M: Glucose-responsive neurons in the brain-stem. Obes Res 3 (Suppl. 5):735S-740S, 1995
27. Jodka C, Green D, Young A, Gedulin B: Amylin modulation of gastric emptying in rats depends upon an intact vagus nerve (Abstract). Diabetes 45 (Suppl. 1):235A, 1996